RenaissanceRe Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RenaissanceRe in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RenaissanceRe stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RNR, but not buy additional shares or sell existing shares.
View analyst ratings for RenaissanceRe or view top-rated stocks.

Wall Street analysts have given RenaissanceRe a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but RenaissanceRe wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

RenaissanceRe is scheduled to release its next quarterly earnings announcement on Tuesday, October 26th 2021.
View our earnings forecast for RenaissanceRe.

RenaissanceRe Holdings Ltd. (NYSE:RNR) issued its quarterly earnings results on Thursday, July, 22nd. The insurance provider reported $5.64 EPS for the quarter, topping the Zacks' consensus estimate of $4.74 by $0.90. The insurance provider earned $1.51 billion during the quarter, compared to the consensus estimate of $1.50 billion. RenaissanceRe had a trailing twelve-month return on equity of 1.51% and a net margin of 8.54%. RenaissanceRe's revenue was up 28.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.06 EPS.
View RenaissanceRe's earnings history.

RenaissanceRe's stock was trading at $155.96 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RNR shares have decreased by 8.2% and is now trading at $143.22.
View which stocks have been most impacted by COVID-19.

RenaissanceRe declared a quarterly dividend on Wednesday, July 28th. Stockholders of record on Wednesday, September 15th will be paid a dividend of $0.36 per share on Thursday, September 30th. This represents a $1.44 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date is Tuesday, September 14th.
View RenaissanceRe's dividend history.

RenaissanceRe pays an annual dividend of $1.44 per share and currently has a dividend yield of 1.00%. The dividend payout ratio of RenaissanceRe is 1,200.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, RenaissanceRe will have a dividend payout ratio of 8.73% next year. This indicates that RenaissanceRe will be able to sustain or increase its dividend.
View RenaissanceRe's dividend history.

5 brokers have issued 12-month target prices for RenaissanceRe's shares. Their forecasts range from $162.00 to $220.00. On average, they expect RenaissanceRe's stock price to reach $189.80 in the next year. This suggests a possible upside of 32.5% from the stock's current price.
View analysts' price targets for RenaissanceRe or view top-rated stocks among Wall Street analysts.

6 employees have rated RenaissanceRe CEO Neill A. Currie on Glassdoor.com. Neill A. Currie has an approval rating of 100% among RenaissanceRe's employees. This puts Neill A. Currie in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to RenaissanceRe include Everest Re Group (RE), Alleghany (Y), Reinsurance Group of America (RGA), Enstar Group (ESGR), Maiden (MHLD) and Greenlight Capital Re (GLRE).
View all of RNR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other RenaissanceRe investors own include Advanced Micro Devices (AMD), Xilinx (XLNX), Exxon Mobil (XOM), The Home Depot (HD), Verizon Communications (VZ), Bank of America (BAC), Keysight Technologies (KEYS), NVIDIA (NVDA), Fortinet (FTNT) and Intel (INTC).

RenaissanceRe trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNR."

RenaissanceRe's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.54%), BlackRock Inc. (9.83%), Price T Rowe Associates Inc. MD (6.87%), State Street Corp (5.30%), FMR LLC (3.08%) and TimesSquare Capital Management LLC (2.85%).
View institutional ownership trends for RenaissanceRe.

RNR stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., American Century Companies Inc., FMR LLC, Alliancebernstein L.P., APG Asset Management N.V., Boston Partners, Swiss National Bank, and Credit Suisse AG.
View insider buying and selling activity for RenaissanceRe or view top insider-selling stocks.

RNR stock was purchased by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Sound Shore Management Inc. CT, JPMorgan Chase & Co., Cooke & Bieler LP, Renaissance Technologies LLC, Millennium Management LLC, Victory Capital Management Inc., and First Trust Advisors LP.
View insider buying and selling activity for RenaissanceRe or or view top insider-buying stocks.

Shares of RNR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RNR stock can currently be purchased for approximately $143.22.

RenaissanceRe has a market capitalization of $6.75 billion and generates $5.17 billion in revenue each year. The insurance provider earns $762.41 million in net income (profit) each year or $0.12 on an earnings per share basis.

RenaissanceRe employs 604 workers across the globe.

The official website for RenaissanceRe is www.renre.com.

RenaissanceRe is headquartered at RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19.

RenaissanceRe's mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The insurance provider can be reached via phone at (441) 295-4513 or via email at [email protected].